Table 4 In-hospital MACEs and bleeding events in the BUDO and BUDAO groups.

From: Prolonged infusion of bivalirudin after elective percutaneous coronary intervention protects against procedural myocardial injury (a COBER study)—a randomized trial

Variables

BUDO group (n = 165)

BUDAO group (n = 165)

P value

MACEs (%)

1 (0.60%)

0 (0.00%)

1.000

TV-AMI (%)

1 (0.60%)

0 (0.00%)

 

TVR (%)

0 (0.00%)

0 (0.00%)

 

TV-CD (%)

1 (0.60%)

0 (0.00%)

 

Bleeding events (BARC grading)

0 (0.00%)

2 (1.21%)

0.498

1 (%)

0 (0.00%)

0 (0.00%)

 

2 (%)

0 (0.00%)

1 (0.60%)

 

3 (%)

0 (0.00%)

1 (0.60%)

 

4 (%)

0 (0.00%)

0 (0.00%)

 

5 (%)

0 (0.00%)

0 (0.00%)

 
  1. Data were expressed as n (%). MACEs Major adverse cardiac events; TV-AMI Target vessel-acute myocardial infarction; TVR Target vessel revasculization; TV-CD Target vessel-cardiac death; BARC Bleeding academic research consortium.
Back to article page